Redmile Group, LLC Portfolio Holdings

Redmile Group, LLC

  • $1.53 Billion
  • Q3 2024

Redmile Group, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.53 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Krystal Biotech, Inc. with a value of $147M, Nurix Therapeutics, Inc. with a value of $96.1M, Amicus Therapeutics, Inc. with a value of $88.1M, Immunome Inc. with a value of $71.5M, and Kymera Therapeutics, Inc. with a value of $65.9M.

Examining the 13F form we can see an decrease of $4.32M in the current position value, from $1.53B to 1.53B.

Redmile Group, LLC is based out at San Francisco, CA

Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.53 Billion
Healthcare: $1.52 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$60.3M
$2.09 Million 0.14% of portfolio
442,826
Q1 2024 Reduced 67.78%
$77.1M
$2 Million 0.13% of portfolio
3,077,828
Q2 2024 Reduced 10.82%
$43.6M
$1.64 Million 0.11% of portfolio
1,608,089
Q1 2022 Reduced 22.99%
$51.2M
$1.55 Million 0.1% of portfolio
1,907,969
Q3 2022 Added 131.73%
$32M
$1.01 Million 0.07% of portfolio
504,532
Q3 2024 Reduced 5.99%
$108M
$679,000 0.04% of portfolio
715,607
Q2 2023 New
Hookipa Pharma Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Oruka Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 4.87%
Atara Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Biohaven LTD
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 4.91%
Boundless Bio Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 1.07%
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 2.09%

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $1.53 Billion
  • Prior Value $1.53 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 32 stocks
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email